Versant V Luxco S.a R.l. - Net Worth and Insider Trading
Versant V Luxco S.a R.l. Net Worth
The estimated net worth of Versant V Luxco S.a R.l. is at least $15 Million dollars as of 2024-04-27. Versant V Luxco S.a R.l. is the 10% Owner of Aprea Therapeutics Inc and owns about 2,852,656 shares of Aprea Therapeutics Inc (APRE) stock worth over $15 Million. Details can be seen in Versant V Luxco S.a R.l.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant V Luxco S.a R.l. has not made any transactions after 2019-10-07 and currently still holds the listed stock(s).
Transaction Summary of Versant V Luxco S.a R.l.
Versant V Luxco S.a R.l. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant V Luxco S.a R.l. owns 1 companies in total, including Aprea Therapeutics Inc (APRE) .
Click here to see the complete history of Versant V Luxco S.a R.l.’s form 4 insider trades.
Insider Ownership Summary of Versant V Luxco S.a R.l.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-04-09 | 10 percent owner |
Versant V Luxco S.a R.l. Latest Holdings Summary
Versant V Luxco S.a R.l. currently owns a total of 1 stock. Versant V Luxco S.a R.l. owns 2,852,656 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $15 Million.
Latest Holdings of Versant V Luxco S.a R.l.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 2,852,656 | 5.20 | 14,833,811 |
Holding Weightings of Versant V Luxco S.a R.l.
Versant V Luxco S.a R.l. Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant V Luxco S.a R.l. has made a total of 1 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 333,333 shares on October 7, 2019, which cost Versant V Luxco S.a R.l. around $5 Million.
Insider Trading History of Versant V Luxco S.a R.l.
- 1
Versant V Luxco S.a R.l. Trading Performance
GuruFocus tracks the stock performance after each of Versant V Luxco S.a R.l.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant V Luxco S.a R.l. is 115.11%. GuruFocus also compares Versant V Luxco S.a R.l.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant V Luxco S.a R.l. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Versant V Luxco S.a R.l.'s insider trading performs compared to the benchmark.
Performance of Versant V Luxco S.a R.l.
Average Return
44.99%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.41 | 115.11 | 59.16 | 44.99 | -49.47 | -67.7 |
| Relative Return to S&P 500(%) | 14.43 | 104.96 | 68.67 | 28.68 | -71.79 | -75.08 |
Versant V Luxco S.a R.l. Ownership Network
Ownership Network List of Versant V Luxco S.a R.l.
Ownership Network Relation of Versant V Luxco S.a R.l.
Versant V Luxco S.a R.l. Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Versant V Luxco S.a R.l. is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Versant V Luxco S.a R.l. made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Versant V Luxco S.a R.l. Mailing Address
Above is the net worth, insider trading, and ownership report for Versant V Luxco S.a R.l.. You might contact Versant V Luxco S.a R.l. via mailing address: 15, Boulevard F.w. Raiffeisen, Luxembourg N4 L-2411.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
